AIDS Drug Recalled
Share
Public health experts are worried that incomplete information on the recall of the AIDS drug Viracept by the pharmaceutical company Roche is leaving AIDS victims in poor countries with a Catch-22: take their AIDS meds on schedule and risk the potential for a contaminated batch; or stop taking the drug as part of their regime, and risk the health effects of incomplete treatment.
Check out today’s New York Times for an article on the recall.
- Previous Post Beating HIV/AIDS: Treatment or Prevention?
- Next Post Ask Mitt Anything
 |
 |
 |
Featured Series
About the Blog
The ONE Blog is a daily log of the anti-poverty movement. The site is operated by ONE staff, with frequent contributions from volunteers, members and partner organizations.
The ONE Blog updates readers daily with the latest in global development news and analysis and what ONE members and our partners are doing around the world to influence world leaders in the fight against global poverty.
The content of each post and each comment represents the views of that author and does not necessarily reflect the views of ONE or ONE Action. ONE does not support or oppose any candidate for elected office, and any post expressing support or opposition for a candidate is not endorsed by ONE.
